1. Lifelong Awareness of the Incidence of Inhibitors and Risk Factors | |
2. Early Recognition and accurate diagnosis | |
3. Organisation of Care and Communication Between All Stakeholders | |
4. Inhibitor eradication by Immune Tolerance Induction Therapy | |
5. Hemostatic Treatment with Bypassing Agents | |
6. Access to and Optimal Preparation for Surgery and Invasive Procedures | |
7. Delivery of Specialist Nursing Care | |
8. Provision of Tailored Physiotherapy Care | |
9. Access to Psychosocial Support | |
10. Involvement in the Research and Innovation |